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MR/GR Signaling in the Brain 
during the Stress Response
Edo R. de Kloet and Onno C. Meijer
Abstract
This contribution is about mineralocorticoid receptors (MRs) in their capacity 
as mediators of glucocorticoid action in the brain. This paradox has evolved because 
MRs are promiscuous and bind with high-affinity cortisol and corticosterone as well 
as aldosterone, deoxycorticosterone, and progesterone. The MRs “see,” however, pre-
dominantly glucocorticoids, because of their 100–1000-fold excess over aldosterone; 
bioavailability is further enhanced because of local regeneration of glucocorticoids by 
11βOH-steroid dehydrogenase (HSD-1). In contrast to these glucocorticoid-preferring  
MR, the evolutionary later appearance of aldosterone-selective MR in epithelial cells 
depends on co-localization with the oxidase 11β-hydroxysteroid-dehydrogenase type 
2 (HSD-2) in a few hundred neurons in the nucleus tractus solitarii (NTS), which 
innervate frontal brain regions to regulate cognitive, emotional, and motivational 
aspects of salt appetite. The glucocorticoid-MRs and classical glucocorticoid recep-
tors (GRs) mediate in a complementary manner the glucocorticoid coordination of 
circadian events and mediate the regulation of stress coping and adaptation. If an 
individual is exposed to a threat, MRs are crucial for the selection of a particular cop-
ing style, which is via GR activation subsequently stored in the memory for future 
use. Our contribution is concluded with the notion that an imbalance in MR- and 
GR-mediated actions increases susceptibility to stress-related disorders.
Keywords: stress, brain, behavior, inflammation, glucocorticoid receptors, 
mineralocorticoid receptors
1. Introduction
The naturally occurring glucocorticoids, cortisol and corticosterone (the latter 
only in rodents), are secreted as end products of the hypothalamus-pituitary-
adrenal (HPA) axis. The glucocorticoids have two modes of operation. Firstly, the 
hormones synchronize and coordinate circadian and sleep-related events. This 
action is based on hourly ultradian pulses with increasing amplitude toward the 
start of the active period with the goal to generate the necessary energy for the day 
to come. The hourly pulses maintain responsivity to the glucocorticoids. The fre-
quency and amplitude of the glucocorticoid pulses may change as is the case during, 
e.g., inflammatory disorders and depression, or may become irregular as part of the 
aging process. High glucocorticoid concentrations prevent the onset of sleep [1–3].
Secondly, the glucocorticoids mediate the response to stress. A “stress reac-
tion” can be due to physical stimuli such as pain, blood loss, and infection or can 
be psychogenic. Anticipation is an important component of the psychogenic stress 
reaction. Hence, the prediction of an upcoming event and the ability to exert 
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control are essential for effective coping irrespective whether it concerns an adverse 
experience or a reward. Actually, stress is the “spice of life” and essential for adapta-
tion and survival. However, the most severe stressor is characterized by inability to 
predict upcoming events and uncertainty during a threat. If uncertainty because of 
lack of control persists, the very same glucocorticoids that promote adaptation are 
now disruptive, facilitate breakdown of adaptation, reduce resilience, and enhance 
vulnerability to disease [4].
Glucocorticoid secretion from the adrenocortical zona fasciculata is under the 
control of pituitary adrenocorticotropic hormone (ACTH) that is cleaved from the 
large precursor molecule: pro-opiomelanocortin (POMC). The anterior pituitary 
synthesis of POMC is driven by corticotropin-releasing hormone (CRH) from 
neurosecretory cells of the paraventricular nucleus (PVN) in the hypothalamus; co-
localized vasopressin amplifies the CRH-induced release of ACTH. Physical stress-
ors directly activate CRH neurons via ascending neuronal projections of the brain 
stem. Psychological stressors are processed in higher brain regions for appraisal, 
decision-making, and choice of coping style to deal with the stressor. At last, the 
stress reaction dissipates and the experience is stored in the memory [5].
2. Corticosteroid receptors
The action of glucocorticoids is mediated by two types of corticosteroid 
receptors. One type is, surprisingly, the mineralocorticoid receptor (MR). This 
receptor was first identified in 1968 by Bruce McEwen: retention of 3H-labeled 
corticosterone was observed in hippocampal neurons at 1 hour after administra-
tion of the tracer to an adrenalectomized (ADX) rat [6]. 3H-aldosterone given to 
ADX animals showed essentially the same neuroanatomical distribution pattern as 
3H-corticosterone. The MR was cloned: immunoreactive (ir) MR protein and MR 
gene expression showed the same distribution pattern as radioligand binding in the 
hippocampus [7, 8].
The GR was initially not detected by in vivo radioligand binding studies for two 
reasons. Firstly, the amount of radiolabeled corticosterone tracer was insufficient 
to occupy GR, because this receptor binds cortisol and corticosterone with a tenfold 
lower-affinity than the high-affinity MR. Second, our in vivo tracer studies with 
the high-affinity GR ligand, dexamethasone, did not provide a signal in the brain 
because the synthetic steroid was exported by multidrug resistance P-glycoprotein 
localized in the blood-brain barrier. When pure glucocorticoids became available, 
we managed to identify distinct populations of MR and GR in vitro. GR was found 
widely distributed in the brain and highly expressed in the typical stress centers. 
MR and GR are abundant and co-localized in limbic neurons [9, 10].
The MRs actually occur as glucocorticoid-preferring and aldosterone-selective 
variations in receptor function. Aldosterone-selectivity occurs solely in epithelial 
cells engaged in Na homeostasis. In a collaborative study with Edwards et al., we 
discovered in 1988 that aldosterone selectivity hinges on co-expression with the 
enzyme 11β-hydroxysteroid-dehydrogenase type 2 (HSD-2), which breaks down 
the naturally occurring glucocorticoids, cortisol and corticosterone, into their inac-
tive 11-dehydro congeners [11]. The Australian group led by John Funder reached 
the same conclusion [12]. In the brain, the aldosterone-selective MRs involved in salt 
homeostasis are mostly restricted to neurons of the nucleus tractus solitarii (NTS) 
and the circumventricular organs. The MR-NTS neurons project to limbic forebrain 
regions, notably the locus coeruleus area involved in arousal and the bed nucleus of 
the stria terminalis (BNST). Via the BNST hub, the NTS neurons can affect emo-
tions, memory performance, and reward processing [13–15].
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A pharmacological amount of aldosterone, administered to rats, is anxiogenic 
and causes changes in coping with stress [16]. Such an effect can be explained by 
overstimulation of the aldosterone-responsive brain network. In fact, patients 
suffering from essential hypertension have an enhanced aldosterone secretion 
following stress exposure [17]. It would be of interest, therefore, to further explore 
this line of research, particularly in light of the persistent evidence of excess 
mineralocorticoids and aberrant MRs as risk factors for mood disorders [18, 19], 
also in patients with Conn’s syndrome [20]. In addition, the brain aldosterone MRs 
were found to be causal in hypertension in case a high-salt diet was offered [21], see 
overview on aldosterone and mineralocorticoid receptors [22].
The majority of MRs that are abundantly expressed in limbic-frontocortical 
neurons were identified as glucocorticoid-preferring. This is because cortisol and 
corticosterone are present in a 100–1000-fold excess over aldosterone, thus 
competing out aldosterone binding, even though part of the circulating gluco-
corticoid is bound to corticosteroid-binding globulin (CBG). Accordingly, these 
glucocorticoid-preferring MRs predominantly “see” the naturally occurring 
glucocorticoids, cortisol and corticosterone. Moreover, glucocorticoid preference 
is further enhanced by co-expression with HSD-1, which regenerates locally bioac-
tive glucocorticoids from the inactive 11-dehydro congener [23]. Finally, MRs are 
promiscuous in that they bind in addition to glucocorticoids and aldosterone also 
progesterone and deoxycorticosterone. This promiscuity may be related to the fact 
that evolutionary the MRs preceded the GRs, progesterone receptors and androgen 
receptors [24].
Thus, some 30 years ago, we felt as if we were “digging gold.” We knew the 
precise localization of MR and GR in the brain and that these receptors did bind the 
same hormones—cortisol and corticosterone—but with an order of a magnitude 
difference in affinity. This was the start of a systematic search for their molecular, 
cellular, neuroendocrine, and behavioral function, together with the group of 
Marian Joëls in Amsterdam. This helped to define better the temporal, spatial, 
and contextual domains of the stress response that are so extremely important 
for understanding stress coping and adaptation [25–28]. Before discussing MR/
GR function, we will first briefly summarize the main aspects of their role in the 
molecular and cellular mechanisms of glucocorticoids.
3. Molecular mechanisms of MR-/GR-mediated actions
The non-genomic effects notwithstanding (see Section 4) MR and GR are best 
understood as transcription factors involved in the regulation of gene expression. 
Classically, their differential effects have been related to (besides cell-specific 
expression) transcriptional effects that are independent of the highly homologous 
DNA-binding domain. For example, an important part of the anti-inflammatory 
actions of GR activation depends on interactions of GR monomers with pro-
inflammatory transcription factors such as the “nuclear factor kappa-light-chain-
enhancer of activated B cells” (NF-κB), a process called transrepression, and these 
interactions are much weaker for MR [29]. Recently, the interaction of the GR 
monomer with NF-κB was challenged with the discovery of GR binding to “cryptic” 
DNA sequences within the genomic NF-κB response elements (κBREs) that mediate 
GR-driven repression of inflammatory gene expression [30].
Recent studies that evaluated MR and GR binding to the DNA in the hippocam-
pus indicate that the receptors interact with the DNA via their—homologous— 
DNA-binding domains [31–33]. MR and GR share 96% homology in their DNA-
binding domain, and both recognize the same “GRE” sequence in the DNA to 
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which they bind as homo- or heterodimers. Yet, they differ in other parts of the 
protein, in particular in their large N-terminal domain. The best known target 
genes that are shared between MR and GR are FKBP5, Sgk1, GILZ, and PER1. For 
these genes, GR activation seems to extend the MR-mediated action by an order of 
magnitude, as shown in dose-response studies.
Based on genome-wide profiling, many corticosterone-responsive hippocampal 
mRNAs—also in laser-dissected subregions—are known, allowing the identifica-
tion of specific signaling pathways [34–37]. In other brain areas, information 
is more sparse, but likely will differ substantially, as patterns of MR and/or 
GR-responsive target genes overlap only partially between different cell types [38]. 
This cell specificity seems to be the consequence of a different chromatin organiza-
tion and of cell-specific expression of coregulatory proteins that modulate the 
effects of MR and GR, once these are bound to the DNA [39, 40].
In view of their very different effects in the hippocampus, MR and GR should 
have unique target genes, and this assumption indeed recently has been material-
ized in three independent studies [31, 32, 41]. A unique signature of MR binding 
to DNA loci was discovered and found associated with the NeuroD transcription 
factor [33]. Also GR binding appeared associated to some extent with NeuroD, 
possibly as a result of heterodimer formation with MR [42]. Furthermore, current 
data suggest that NeuroD can interact with other unidentified proteins in the tran-
scriptional complex that is formed upon MR binding to DNA. Such a MR-Neuro-D 
complex seems to confine specificity to cortisol action.
In spite of this progress in understanding receptor-specific cortisol actions, 
there is no single GR or MR target gene known to be responsible solely for circuit 
activation underlying a particular behavioral response during stress adaptation. 
Rather, MR and GR seem to be master regulators that mediate in complementary 
manner downstream regulatory networks in a cell- and context-specific fashion 
[37, 43]. Moreover, the transcriptional response of the hippocampal genome to 
corticosterone depends strongly on the recent past of the individual. About half of 
the significantly regulated mRNA’s were found to be different between animals with 
a recent history of stress, as compared to control animals [37, 44].
4. Cellular mechanisms of MR-/GR-mediated action
In hippocampal CA1 neurons, in particular the membrane properties affected 
by norepinephrine (NE), serotonin (5HT), and glutamate are affected by corticos-
terone in a U-shaped dose-response curve [45, 46]. Thus, the activation of 5HT1A 
receptors produced during absence of corticosterone a large increase in conduc-
tance of an inwardly rectifying K-channel, causing the membrane to hyperpolarize. 
MR activation with a low concentration of corticosterone minimized the 5HT1A 
hyperpolarization response [47]. When corticosterone levels increased and gradu-
ally occupied GR, the hyperpolarization response returned, but not in GRdim/dim 
mutants [48], in which cannot dimerize because of point mutation in their DNA 
domain [49]. A similar U-shaped dose response was found for the accommodation 
of firing frequency upon steady depolarization of cells by NE and for the Ca influx 
via L-type voltage-dependent channels [46, 50–52].
The U-shaped dose-response curve is not a common phenomenon in the brain, 
since it is dependent on the presence of both receptor types. Even if both receptors 
are present, such as in the dentate gyrus, other membrane properties are affected 
than in the CA1 neurons. In the dentate gyrus MR activation increased the field 
potential, and the single cell response showed activation of glutamatergic recep-
tors, and both responses were not further affected by additional GR activation 
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[46]. These cellular effects in CA1 and dentate gyrus have not been explained by 
transcriptional regulation. For instance, 5HT1A mRNA expression in CA1 cells was 
not affected by adrenalectomy, while it was in an MR-dependent fashion in dentate 
gyrus neurons [53].
The dentate gyrus is one of the two brain regions where neurogenesis occurs 
throughout life. In the absence of steroids, the turnover of these neurons increases, 
showing increased neurogenesis and apoptotic cell death. Both processes are normal-
ized if the animals are replaced with low doses of corticosterone, just sufficient to 
occupy MR. Glucocorticoids suppress proliferation and migration of the newborn 
neurons via GRs. Lentiviral GR knockdown in the dentate progenitor cells accelerates 
neuronal differentiation and migration. The newborn neurons showed increased 
synaptic contacts and increased excitability and migrated further in establishing 
functional integration in the hippocampal circuitry. Accordingly, contextual fear-
motivated behavior was impaired [54].
Regarding the non-genomic actions, MR mediates the rapid and transient 
increase of miniature excitatory postsynaptic currents (mEPSC) after treatment 
with corticosterone. The putative membrane MR is localized presynaptically and 
activates the release probability of glutamate. The rapid effects were eliminated 
after genetic deletion of the MR gene or with MR antagonists [55]. These effects are 
exerted by both aldosterone and corticosterone, and the dose-response curve sug-
gests a lower affinity of steroid binding to the membrane than to nuclear MR. The 
membrane MR—in spite of much effort—has not been physically demonstrated yet 
[56–58] and likely is similar to the nuclear variant. The MR-enhanced increase of 
glutamate release downregulates the presynaptic metabotropic glutamate receptors 
(mGluR2) [59].
The nature of the membrane-mediated MR effects shows, however, large 
regional differences in the brain. For instance, in contrast to the rapid transient rise 
in excitability, the excitation is long-lasting in basolateral amygdala (BLA) neurons 
due to cooperation with genomic GR-mediated actions. Moreover, the duration of 
BLA excitation is further prolonged if—as is the case during stress—these cells are 
also exposed to NE, which can be mimicked by the β-adrenergic agonist isopro-
terenol. Interestingly, such a prolonged increased excitability of the BLA protects 
against the effect of a second MR-mediated corticosterone pulse, probably via rapid 
endocannabinoid action linked to the membrane GR [60]. These composite cellular 
responses were defined as a manifestation of “corticosterone metaplasticity” and 
may explain why emotions are so strongly remembered [61, 62].
Thus, the data demonstrate that glucocorticoid actions may vary between cell 
groups. This variety in responses also has consequences for the influence of stress 
exposure and stress hormones on long-term potentiation (LTP), a cellular model 
of memory performance. It demonstrates that stress does not a priori disturb LTP, 
since the outcome depends on the context, the previous experiences, the phase of 
the stress response, and the analyzed brain regions [63]. In the hippocampus, MR 
is essential for neuronal viability and maintenance of excitatory transmission. If, 
with increasing corticosterone concentrations, GR becomes occupied, this receptor 
restores transiently raised excitability.
5. Functional cooperation of MR and GR
MRs and GRs cooperate in glucocorticoid regulation, and below we will distin-
guish four different phases of this cooperation in stress coping and adaptation (see 
Figure 1). This distinction is based on temporal and contextual features of mem-
brane and genomic glucocorticoid actions. The conditional nature is an important 
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criterion, since it assigns a specificity to glucocorticoid action. The temporal action 
is also critical. The rapid non-genomic actions wax and wane in correspondence 
with glucocorticoid concentrations. The genomic actions develop minutes to hours 
after glucocorticoid exposure and may last for days or even a lifetime. The latter 
concerns aspects of programming of brain circuitry for later life by epigenetic pro-
cesses at glucocorticoid targets or even the receptors themselves [66]. The following 
phases in glucocorticoid action can be distinguished:
Phase 1—basal is the basal state in which during the circadian/ultradian cycle, 
mostly genomic MRs are occupied during the trough, and, subsequently, when glu-
cocorticoid levels show their hourly increases, the hormone progressively activates 
additional GRs. The continuous MR activation is a determinant of the threshold or 
sensitivity of the stress response system. The transient GR activation by the hourly 
pulses maintains responsivity to sudden changes in glucocorticoid secretion as they 
occur in response to stress [3, 9, 67].
Phase 2—onset is the onset of the stress reaction when a novel experience is 
anticipated or actually happens and triggers sympathetic activation and CRH 
release. Non-genomic MRs that are rapidly activated by a stress-induced increase 
in circulating glucocorticoids enhance attention and vigilance to optimize sensory 
processing in support of perception and appraisal of novel information [68]. 
MR activation promotes memory retrieval in the hippocampus to deploy the 
previously used strategy in stress coping and enhances in amygdala emotional 
expressions of fear and aggression [69, 70]. MR activation also facilitates the 
choice of coping style. For instance, under mild stress conditions, most indi-
viduals will opt for a coping strategy involving the hippocampus (thinking). 
However, when stressors become more severe and less controllable, increasingly 
an emotion-driven habitual amygdala-striatal stimulus-response coping strategy 
is preferred (doing). The switch from “thinking to doing” depends on limbic 
MR. Corticosterone administration promotes habit formation, while MR antago-
nists prevent the switch and the slower, costlier hippocampal cognitive strategy 
Figure 1. 
Four phases of MR/GR signaling in the brain during the stress response. Phase 1: “Basal” MR/GR signaling 
during ultradian/circadian activity is a determinant of the sensitivity of the stress response. Phase 2: “Onset” 
of the stress reaction non-genomic MR-mediated actions promotes appraisal processes, retrieval of previously 
stored information, selection of coping style, and encoding of the experience for learning, all directed to defend 
the “self.” Phase 3: “Termination” is the negative feedback action of GR-mediated glucocorticoid action aimed 
to prevent defense reactions from overshooting. Via GR, the experience is contextualized in the hippocampus 
and rationalized in the prefrontal cortex, with more “altruistic” solutions that increase motivation to assign 
a valence to social solutions and rewards. Phase 4: “Priming” refers to memory storage of the experience for 
future use (adapted from [27, 28, 64, 65]).
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is maintained. Finally, via MRs the context of the experience and the selected 
coping style are encoded for learning [71–73].
Phase 3—termination marks a further increase of glucocorticoid secretion and 
progressive activation of the lower-affinity membrane and genomic GRs, which 
are in limbic-frontocortical structures co-localized with MRs [25, 28]. The MRs are 
continuously involved in appraisal processes to monitor the outcome of the stress-
coping strategy. GR function limits defense reactions to prevent these from over-
shoot that may cause damage, if not dampened [74]. These defense mechanisms 
are now abolished, and it is time for rationalization and contextualization of the 
experience and for assessment of valence as occurs in social interactions [27, 75]. At 
the same time, GR activation drives via a mitochondrial mechanism energy alloca-
tion to cells and circuits in need to facilitate recovery from the stressor [76]. This is 
a life-sustaining action since complete GR knockouts do not survive, while GRdim/
dim do. After all, lack of glucocorticoids is not compatible with life as is illustrated by 
adrenalectomy and in the case of Addison’s disease. Phase 3 is also characterized by 
increased motivational arousal, emotional expressions, and reinforcement learn-
ing, accompanied by increased gene expression of key components in the amygdala 
(re: enhanced CRH expression) and ventral striatum—frontocortical circuitry (re: 
increased dopaminergic function) [77–81].
Phase 4—priming GR activation in the limbic-frontocortical circuits promotes 
storage of contextual and emotional-loaded information in the memory. This 
consolidation process takes a couple of hours after the stressful experience [82]. 
Synaptic adaptations occur which can be measured with fMRI and are characterized 
by genome-wide transcriptional signatures [83–85]. Growth factors such as BDNF 
participate by acting in the dentate neurogenic niche; also growth factor actions in 
e.g. mPFC and mesolimbic dopaminergic systems [86, 87] are all involved. Hence, 
GR-activated memory storage prepares for the future, so that stored information 
can be retrieved again in the proper context. During phases 3 and 4, the individual’s 
homeostasis is restored and behavioral adaptation is promoted [4].
Using optogenetics combined with neuroanatomical tracing, the top-down  
organization of the brain’s coping circuitry is rapidly unraveled today. Accordingly, the  
prelimbic mPFC sends excitatory projections to the lateroventral (av)-BNST, 
which operates as an inhibitory GABAergic hub over downstream neuroendocrine, 
autonomic, and behavioral responses [88]. Stressors activate the excitatory output 
of the mPFC, which translates into BNST-dependent inhibition of CRH neurons 
in the PVN and results in suppression of the HPA axis response. In another group 
of CRH neurons, the BNST input attenuates the sympathetic output. A separate 
pathway of the BNST projects to the ventrolateral periaqueductal (vl-PAG) where 
passive coping is promoted at the expense of the initial active coping strategy [89, 
90]. Active coping refers to fight or flight, which, when the situation is appraised 
as inescapable, causes a reorganization of prelimbic to infralimbic mPFC circuitry 
that is aimed to restrain the emotional and autonomic responses [91–94]. Passive 
conservation withdrawal behavior is promoted allowing recuperation and storage 
of energy resources [95, 96].
This coping circuit is modulated in function by contextual information from 
the hippocampus, by emotional- and fear-input from the amygdala, visceral and 
autonomous inputs from the brain stem, and motivational arousal associated with 
valence assessment from the ventral striatum. The coping circuit and its modulat-
ing inputs are all targets of the glucocorticoids that convey environmental and 
physiological information. This bottom-up control exerted by the glucocorticoids 
is mediated by the MR and GR in a complementary manner along the four differ-
ent phases of stress coping and adaptation [64] (see Figure 1). The action of the 
glucocorticoid during stress coping and adaptation has led to the formulation of 
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the MR/GR balance hypothesis, which states that “upon imbalance of the MR- and 
GR-mediated actions, the initiation and/or management of the stress response 
becomes compromised. At a certain threshold this may lead to a condition of neuro-
endocrine dysregulation and impaired behavioral adaptation, which potentially can 
aggravate stress-related deterioration and promote vulnerability” [9, 25, 28, 97–99].
6. Implications for pathogenesis and treatment of stress-related diseases
Physical or psychogenic stressors promote activation of circuits that underlie 
appraisal and decision-making processes, which are important for selection of an 
appropriate coping style to support physiological and behavioral adaptations. The 
most severe psychogenic stressor is lack of control and inability to predict, with an 
uncertain fearful feeling [96, 100]. The brain can adapt to this situation by prolifera-
tion of the emotional amygdala and atrophy of the hippocampus, ventral striatum, 
and prefrontal cortex [101–104]. Glucocorticoid secretion remains elevated and energy 
resources are drained. Essential defense mechanisms become compromised, and 
when then confronted with a novel stressor, coping fails, breakdown of adaptation is 
facilitated, and vulnerability to mood and anxiety disorders increases [105, 106].
Adverse (early) life experience and unfavorable socioeconomic conditions are 
important predisposing factors for such stress-related disorders [107]. Also genetic 
variants and epigenetic modifications are increasingly recognized as biomarkers 
of susceptibility and vulnerability. For instance, for MR, two functional SNPs 
(rs2070951 and rs5522) constitute a block of four haplotypes. Haplotype 2 generates 
in vitro the highest MR-binding capacity and transactivation. Carriers of haplotype 
2 display a preferential habit rather than cognitive strategy in coping with stress. 
Haplotype 2 (C/A frequency 35%) is associated with optimism and protection to 
depression and predicts a higher efficacy of antidepressants [73, 108–110]. Actually, 
the MR is a promising target to facilitate the action of antidepressants [111].
Progress is made in exploiting the relevance of the MR/GR balance for devising 
preventive or curative strategies in the treatment of mental health. For instance, 
it is recognized that patients under dexamethasone therapy have very low levels 
of endogenous circulating glucocorticoids. While dexamethasone is a potent GR 
ligand, the MR becomes depleted of endogenous hormone, because of suppression 
of the HPA axis. Refill of the MR with cortisol add-on largely eliminates the psycho-
logic/psychiatric side effects of dexamethasone therapy [112–115]. Alternatively, 
the glucocorticoid/progesterone antagonist mifepristone is applied for treatment 
of hyperglycemia in patients suffering from Cushing’s syndrome [116]. Recently, 
selective GR modulators (SGRMs) became available that can target metabolism but 
do not show side effects on pituitary ACTH release [117–119].
7. Concluding remarks
Glucocorticoids, acting via brain MRs and GRs, coordinate multiple functions 
over time with one single goal: to promote stress coping and adaptation. Imbalance 
in the MR-/GR-mediated signaling pathways increases susceptibility to stress-related 
mental and neurodegenerative disorders. These imbalances develop under conditions 
of chronic stress when top-down control exerted by the mPFC over the stress-coping 
circuitry is compromised and the cost of bottom-up glucocorticoid action exceeds its 
benefit. New SGRMs are being developed that target the tissue- and context-specific 
action of glucocorticoids in specific domains of cognition, emotion, and motivation 
and which may assist in targeted therapies of stress-related mental disorders.
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